These results provide evidence for the role of MTAP loss in GBM pathogenesis, as they have shown that MTAP loss is at the core of the two main components of GBM pathogenesis, which are aberrant DNA methylation, a key feature of cancer cells, and the GBM cell stemness. This evidence concerns the gene MTAP and cancer.